Healthy boost for Nycomed shares after pounds 223m profit

NYCOMED AMERSHAM, the Anglo-Norwegian health technology group, yesterday pleased the City with a solid set of results despite tough conditions in some of its important markets.

The company, which produces high-technology equipment to diagnose diseases and test drugs, dispelled some of the stock market's worst fears with a 12 per cent rise in 1998 pre-tax profits to pounds 222.8m. Sales were up 1 per cent to pounds 1.38bn.

The figures were at the top end of analysts' expectations, and triggered a 25p rise in the share price to a five-year high of 460p. The stock was also boosted by the announcement that the group, formed from the 1997 link-up between Britain's Amersham and Norway's Nycomed, had achieved pounds 32m of merger savings and was "firmly on course" to meet its target of pounds 70m annual cost cuts from next year. The final results, the first since the merger, were buoyed by good sales growth in the group's core imaging and drug discovery divisions.

The performance of Nycomed's imaging products, used to diagnose and treat diseases, was one of the City's main worries. The company has been hit hard by a slump in the price of X-ray equipment in the important US market amid fierce competition, and it had been feared that the fall in those products could drag down the whole division.

However, profits in the imaging division, accounting for nearly 60 per cent of group profits, rose 14 per cent to pounds 158.9m. Bill Castell, chief executive, said sales growth in Nycomed's high-technology products had offset the expected collapse in X-ray turnover.

Star performers were the heart-imaging agent Myoview, which experienced a 43 per cent leap in sales, and iodine seeds, used to treat prostate cancer, where turnover more than doubled. Mr Castell said that this year the division should benefit from an improvement in the US X-ray market. "We think that the market has bottomed out and should be flat in 1999," he said.

But even if X-rays recover, they are unlikely to provide much of a fillip for Nycomed, as they are a low-margin product. The key to the group's future growth lies in its more sophisticated, higher-margin equipment. Myoview and iodine seeds are promising products and should grow strongly in the next few years as they increase penetration of the lucrative US market.

The pipeline looks interesting, with an ultrasound heart product and a device to detect Parkinson's disease expected to yield solid sales.

On the drug research side, Nycomed's pledge to buy out its joint venture partner, Pharmacia & Upjohn, in the near term will give it control of a cash-generative business.

The company's promised disposal of its underperforming drug division, which last year suffered a fall in profits due to the Russian financial crisis, will also help to streamline operations.

Michael King, pharmaceutical analyst at SG Securities, believes that, given Nycomed's earnings potential, the shares - on 21 times 1999 forecast earnings of pounds 253m - are a buy.

"I am forecasting earnings growth of 12 to 15 per cent in the long term and I believe that [the share price] is still good value," he said.

News
peoplePaper attempts to defend itself
Voices
voicesWe desperately need men to be feminists too
Life and Style
food + drink
Arts and Entertainment
British actor Idris Elba is also a DJ and rapper who played Ibiza last summer
film
PROMOTED VIDEO
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

IT Project manager - Web E-commerce

£65000 Per Annum Benefits + bonus: Clearwater People Solutions Ltd: If you are...

Trainee / Experienced Recruitment Consultants

£20000 - £25000 per annum + OTE £40,000: SThree: SThree are a global FTSE 250 ...

Trainee Recruitment Consultant - Soho

£20000 - £25000 per annum + OTE £40000: SThree: As a Recruitment Consultant, y...

Trainee Recruitment Consultants - Banking & Finance

£20000 - £25000 per annum + OTE £40,000: SThree: SThree Group have been well e...

Day In a Page

Syria air strikes: ‘Peace President’ Obama had to take stronger action against Isis after beheadings

Robert Fisk on Syria air strikes

‘Peace President’ Obama had to take stronger action against Isis after beheadings
Will Lindsay Lohan's West End debut be a turnaround moment for her career?

Lindsay Lohan's West End debut

Will this be a turnaround moment for her career?
'The Crocodile Under the Bed': Judith Kerr's follow-up to 'The Tiger Who Came to Tea'

The follow-up to 'The Tiger Who Came to Tea'

Judith Kerr on what inspired her latest animal intruder - 'The Crocodile Under the Bed' - which has taken 46 years to get into print
BBC Television Centre: A nostalgic wander through the sets, studios and ghosts of programmes past

BBC Television Centre

A nostalgic wander through the sets, studios and ghosts of programmes past
Secret politics of the weekly shop

The politics of the weekly shop

New app reveals political leanings of food companies
Beam me up, Scottie!

Beam me up, Scottie!

Celebrity Trekkies from Alex Salmond to Barack Obama
Beware Wet Paint: The ICA's latest ambitious exhibition

Beware Wet Paint

The ICA's latest ambitious exhibition
Pink Floyd have produced some of rock's greatest ever album covers

Pink Floyd have produced some of rock's greatest ever album covers

Can 'The Endless River' carry on the tradition?
Sanctuary for the suicidal

Sanctuary for the suicidal

One mother's story of how London charity Maytree helped her son with his depression
A roller-coaster tale from the 'voice of a generation'

Not That Kind of Girl:

A roller-coaster tale from 'voice of a generation' Lena Dunham
London is not bedlam or a cradle of vice. In fact it, as much as anywhere, deserves independence

London is not bedlam or a cradle of vice

In fact it, as much as anywhere, deserves independence
Vivienne Westwood 'didn’t want' relationship with Malcolm McLaren

Vivienne Westwood 'didn’t want' relationship with McLaren

Designer 'felt pressured' into going out with Sex Pistols manager
Jourdan Dunn: Model mother

Model mother

Jordan Dunn became one of the best-paid models in the world
Apple still coolest brand – despite U2 PR disaster

Apple still the coolest brand

Despite PR disaster of free U2 album
Scottish referendum: The Yes vote was the love that dared speak its name, but it was not to be

Despite the result, this is the end of the status quo

Boyd Tonkin on the fall-out from the Scottish referendum